Rethinking Clinical Trials

MARCH 6, 2024

Schell Professor of Management and Applied Economics MIT Sloan School of Management Slides Keywords Food-as-Medicine, Randomized Clinical Trial, Diabetes Key Points Diabetes is common and costly. Payers should have some incentive to improve outcomes because sustained reduction in HbA1c from poor to fair can result in cost savings.

Clinical Trials 143

Clinical Trials Clinical Trials Medicine Trials 143

pharmaphorum

JUNE 8, 2021

That was the damning conclusion of the influential Institute for Clinical and Economic Review (ICER) in the US to yesterday’s approval of Aduhelm (aducanumab), the first new treatment for Alzheimer’s since 2003, which it says has “no evidentiary basis.” Patrizia Cavazzoni (@FDACDERDirector) June 7, 2021.

Drugs 98

Drugs Marketing FDA Approval Trials 98

pharmaphorum

JUNE 2, 2022

And of course, in many cases, these drugs have higher than average price tags compared to the wider market which is due to the limited – or in most cases – non-existent competition within a treatment area.”. They added, “Existing incentives and rewards remain essential, as the economic case for investment in these areas is only marginal.”.

Drugs 52

Drugs Sales Marketing Development 52

pharmaphorum

NOVEMBER 16, 2022

However, R&D efforts into biological medicine have moved into the ascendency in recent times, as the treatments often offer targeted therapy and better outcomes. However, with a price tag of €1.58 However, a recently released report from the organisation could blow the price tag of Zolgensma out of the water.

Gene Therapy 130

Gene Therapy Gene Marketing Development 130

Pharmaceutical Technology

JANUARY 27, 2023

Dr. James George, a research professor at the University of Oklahoma Health Sciences Center, said Cablivi “adds a new aspect to treatment, the prompt recovery of platelets and prompt resolution of transient neurologic symptoms”. However, Sanofi’s agreement is particularly unique in the way that it measures outcomes.

Manufacturing 130

Manufacturing Drugs Research Analyst FDA Approval 130

pharmaphorum

JUNE 15, 2021

The adoption of New Science – a unique combination of the best in science and health technology that address significant unmet patient needs – is delivering more precise and effective treatments, but often at a higher price tag, according to new research. A new economic reality is challenging profitability .

Clinical Trials 90

Clinical Trials Clinical Trials Development Marketing 90

Delveinsight

JULY 22, 2020

New Insight/Data For Research. The data collected in the IoT can support medical research. Patients do not need to visit hospitals to get the basic status of their health conditions. This helps in analysis and diagnosis of health conditions like cardiovascular disease. Research and Development in the IT field.

Doctors 59

Doctors Doctor Marketing Production 59